Effects of Aescusan on Fibrinolytic Plasma Activity in Patients with Hypothyroidism

ABSTRACT

The administration of Aescusan into the complex treatment program of patients with hypothyroidism was found to increase total plasma fibrinolysis almost to the control level, normalize the intensity of non-enzymatic fibrinolysis, considerably elevate the enzymatic lysis of fibrine and more effectively, as compared with standard treatment program, restore normal structure of plasma fibrinolysis.